PDCD1 and neoplasm: According to the cluster labels and references in the clusters, the recent research hotspots included “tumor immune microenvironment”, “clinical research of anti-PD-1 immunotherapy”, “neoadjuvant and adjuvant immunotherapy”, and “radiotherapy combined with immunotherapy”.